Sofinnova Investments’s Astria Therapeutics ATXS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-85,640
Closed -$943K 61
2024
Q3
$943K Buy
85,640
+24,948
+41% +$275K 0.07% 53
2024
Q2
$552K Buy
+60,692
New +$552K 0.03% 68